Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1038/nrmicro1532
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/17041633
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1740-1534
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_7E0CE8B166CA1
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
A. Telenti et al., « Genomics meets HIV-1 », Serveur académique Lausannois, ID : 10.1038/nrmicro1532
Genomics is now a core element in the effort to develop a vaccine against HIV-1. Thanks to unprecedented progress in high-throughput genotyping and sequencing, in knowledge about genetic variation in humans, and in evolutionary genomics, it is finally possible to systematically search the genome for common genetic variants that influence the human response to HIV-1. The identification of such variants would help to determine which aspects of the response to the virus are the most promising targets for intervention. However, a key obstacle to progress remains the scarcity of appropriate human cohorts available for genomic research.